StockData
VOGXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Vogenx, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Sep 17, 2026
$15.92+1.39 (+9.57%)

Close on Oct 19, 2026

Market cap
$86.79M
P/E (TTM)
–
Dividend yield
–

Vogenx, Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Vogenx does not break out revenue by segment, region or product in the tagged data of its filings for this period type.